Stryker's 2017 net sales jump 10%, net loss hits $1B: 5 things to know

Spinal Tech


Stryker reported fourth quarter and full year net sales were up 10 percent in 2017.

Here are five things to know:

1. Full year net sales were up 9.9 percent to $12.4 billion. Orthopedics sales grew 6.6 percent to $4.7 billion while neurotechnology and spine sales jumped 8.2 percent to $2.1 billion. Medsurg had the biggest growth, at 13.6 percent, reaching $5.5 billion for the year. In the fourth quarter, neurotechnology and spine sales grew the most at 10.3 percent, hitting $586 million.

2. Spine sales over the full year dropped 0.4 percent while neurotechnology jumped 13.4 percent. Knee sales increased 7 percent to $1.6 billion while hip sales remained relatively flat, showing just 1.6 percent growth. The trauma and extremities line increased 8.2 percent to $1.4 billion.

3. The company's reported net earnings were down 148.9 percent in the fourth quarter, and Stryker reported a $249 million net loss; for the full year, the net loss reached $1 billion with reported earnings decreasing 38.1 percent.

4. Stryker expects 2018 organic sales to grow 6 percent to 6.5 percent.

5. U.S. sales were up 10.1 percent in 2017, hitting $9 billion. International sales also grew 9.4 percent, reaching $3.3 billion.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers